HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Osteogenesis imperfecta due to mutations in non-collagenous genes: lessons in the biology of bone formation.

AbstractPURPOSE OF REVIEW:
Osteogenesis imperfecta or 'brittle bone disease' has mainly been considered a bone disorder caused by collagen mutations. Within the last decade, however, a surge of genetic discoveries has created a new paradigm for osteogenesis imperfecta as a collagen-related disorder, where most cases are due to autosomal dominant type I collagen defects, while rare, mostly recessive, forms are due to defects in genes whose protein products interact with collagen protein. This review is both timely and relevant in outlining the genesis, development, and future of this paradigm shift in the understanding of osteogenesis imperfecta.
RECENT FINDINGS:
Bone-restricted interferon-induced transmembrane (IFITM)-like protein (BRIL) and pigment epithelium-derived factor (PEDF) defects cause types V and VI osteogenesis imperfecta via defective bone mineralization, while defects in cartilage-associated protein (CRTAP), prolyl 3-hydroxylase 1 (P3H1), and cyclophilin B (CYPB) cause types VII-IX osteogenesis imperfecta via defective collagen post-translational modification. Heat shock protein 47 (HSP47) and FK506-binding protein-65 (FKBP65) defects cause types X and XI osteogenesis imperfecta via aberrant collagen crosslinking, folding, and chaperoning, while defects in SP7 transcription factor, wingless-type MMTV integration site family member 1 (WNT1), trimeric intracellular cation channel type b (TRIC-B), and old astrocyte specifically induced substance (OASIS) disrupt osteoblast development. Finally, absence of the type I collagen C-propeptidase bone morphogenetic protein 1 (BMP1) causes type XII osteogenesis imperfecta due to altered collagen maturation/processing.
SUMMARY:
Identification of these multiple causative defects has provided crucial information for accurate genetic counseling, inspired a recently proposed functional grouping of osteogenesis imperfecta types by shared mechanism to simplify current nosology, and has prodded investigations into common pathways in osteogenesis imperfecta. Such investigations could yield critical information on cellular and bone tissue mechanisms and translate to new mechanistic insight into clinical therapies for patients.
AuthorsJoan C Marini, Adi Reich, Simone M Smith
JournalCurrent opinion in pediatrics (Curr Opin Pediatr) Vol. 26 Issue 4 Pg. 500-7 (Aug 2014) ISSN: 1531-698X [Electronic] United States
PMID25007323 (Publication Type: Journal Article, Research Support, N.I.H., Intramural, Review)
Chemical References
  • Antigens, Differentiation
  • CREB3L1 protein, human
  • CRTAP protein, human
  • Cyclic AMP Response Element-Binding Protein
  • Extracellular Matrix Proteins
  • Eye Proteins
  • HSP47 Heat-Shock Proteins
  • IFITM5 protein, human
  • Ion Channels
  • Membrane Glycoproteins
  • Membrane Proteins
  • Molecular Chaperones
  • Nerve Growth Factors
  • Nerve Tissue Proteins
  • Proteoglycans
  • SERPINH1 protein, human
  • Serpins
  • Sp7 Transcription Factor
  • Sp7 protein, human
  • TMEM38B protein, human
  • Transcription Factors
  • WNT1 protein, human
  • Wnt1 Protein
  • leu-13 antigen
  • pigment epithelium-derived factor
  • cyclophilin B
  • Prolyl Hydroxylases
  • P3H1 protein, human
  • BMP1 protein, human
  • Bone Morphogenetic Protein 1
  • Cyclophilins
  • Tacrolimus Binding Proteins
  • FKBP10 protein, human
Topics
  • Antigens, Differentiation (genetics)
  • Bone Morphogenetic Protein 1 (genetics)
  • Cyclic AMP Response Element-Binding Protein (genetics)
  • Cyclophilins (genetics)
  • Extracellular Matrix Proteins (genetics)
  • Eye Proteins (genetics)
  • HSP47 Heat-Shock Proteins (genetics)
  • Humans
  • Ion Channels (genetics)
  • Membrane Glycoproteins (genetics)
  • Membrane Proteins (genetics)
  • Molecular Chaperones
  • Mutation
  • Nerve Growth Factors (genetics)
  • Nerve Tissue Proteins (genetics)
  • Osteogenesis (genetics)
  • Osteogenesis Imperfecta (genetics, pathology)
  • Prolyl Hydroxylases
  • Proteoglycans (genetics)
  • Serpins (genetics)
  • Sp7 Transcription Factor
  • Tacrolimus Binding Proteins (genetics)
  • Transcription Factors (genetics)
  • Wnt1 Protein (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: